Open access
Aug 2026
Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China
This post-marketing, real-world study compared the risk of ADs between females who received bivalent human papillomavirus (HPV) vaccine (Cecolin) and unvaccinated females, providing real-world evidence further confirming that Cecolin vaccination does not increase the risk of ADs.
Xue-Yang Zeng, Xiaoshan Yu, Qiufen Zhang et al.
· Vaccines · 0 citations